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ABSTRACT 
Recent findings relate obesity to inflammation in key hypothalamic areas for body weight 
control. Hypothalamic inflammation has also been related to oxidative stress. Palmitic acid 
(PA) is the most abundant free fatty acid found in food, and in vitro studies indicate that it 
triggers a pro-inflammatory response in the brain. Melanocortins are neuropeptides with 
proven anti-inflammatory and neuroprotective action mediated by melanocortin receptor 4 
(MC4R), but little is known about the effect of melanocortins on oxidative stress. The aim of 
this study was to investigate whether melanocortins could alleviate oxidative stress induced 
by a high fat diet (HFD) model. We found that NDP-MSH treatment decreased PA-induced 
reactive oxygen species (ROS) production in astrocytes, an effect blocked by the MC4R 
inhibitor JKC363. NDP-MSH abolished nuclear translocation of Nrf2 induced by PA and 
blocked the inhibitory effect of PA on superoxide dismutase (SOD) activity and glutathione 
(GSH) levels while it also per se increased activity of SOD and γ-glutamate cysteine ligase 
(γ-GCL) antioxidant enzymes. However, HFD reduced hypothalamic MC4R and BDNF 
mRNA levels, thereby preventing the neuroprotective mechanism induced by melanocortins. 
 
1. INTRODUCTION 
Obesity has developed as a major health concern, its rate of incidence tripling since 1975. 
According to the World Health Organization, in 2016 more than 1.9 billion adults 18 years 
and older were overweight and over 650 million were obese. If this trend continues, it is 
estimated that 51% of the world’s adult population will be obese by 20301. 
Consumption of high fat diets (HFD) is crucial for the development of obesity. Excessive 
intake of fatty acids induces a chronic low-grade inflammatory response that affects both 
peripheral tissues and central nervous system (CNS)2.In vivo studies have shown that high-
fat feeding increases cytokine levels and pro-inflammatory signaling in the hypothalamus 
through TLR4 activation3, leading to neuronal death4 and leptin and insulin signaling 
impairment2,5. Interestingly, hypothalamic inflammation appears long before the onset of 
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Inflammation and oxidative stress are linked in obesity. Pro-inflammatory signaling pathways 
activated in obesity increase production of reactive oxygen species (ROS)7 which, in turn, 
exacerbate the inflammatory response8. Moreover, disturbances in antioxidant enzyme 
activity and increase in oxidative stress markers have been found in plasma of obese 
animals9. Saturated fatty acids are known to induce neurotoxicity and oxidative stress in the 
CNS. Palmitic acid (PA) is the most abundant free fatty acid found in food, and in vitro 
studies indicate that PA induces TNF-α, IL-1β and IL-6 release in astrocytes and 
microglia10,11. In addition, PA increases ROS production in astrocytes12. In the 
hypothalamus, astroglial cells are involved in detection and transport of nutrients13 and also 
express receptors for hormones and neuropeptides whose activation directly affects neurons 
that control metabolic homeostasis14. HFD also induces reactive gliosis, a phenomenon that 
persists after the onset of obesity2. Activated astrocytes promote blood brain barrier 
disruption15, enhancement of diet reward properties in the mesolimbic system16, and 
synaptic changes in the melanocortin system17, thereby perpetuating diet-induced obesity. 
Melanocortins are a group of neuropeptides that includes adrenocorticotropic hormone and 
α, β and γ-melanocyte-stimulating hormones (MSH) which have protective actions in the 
brain18,19. Melanocortin actions are mediated by their five receptor subtypes (MC1R to 
MC5R). In the CNS, MC4R is the most widely distributed subtype. α–MSH, the endogenous 
MC4R agonist, has a physiological effect on feeding and energy homeostasis. α–MSH also 
exerts neuroprotective effects in different in vivo models of ischemia and inflammation by 
decreasing the expression of pro-inflammatory cytokines20 and inducing neurogenesis with 
functional recovery21. Our group determined that both astrocytes and microglia express 
MC4R22,23 and we also demonstrated that MC4R mediates the anti-inflammatory effect of 
melanocortins in astrocytes22, microglia23, and hypothalamus19. While anti-inflammatory 
actions of melanocortins in the CNS have been studied, the melanocortin effect on 
antioxidant response was explored only in skin cells where α–MSH reduces ROS production 
and stimulates antioxidant defenses24. Considering that melanocortins have proven anti-
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melanocyte-stimulating hormone (NDP-MSH), an α–MSH analogue, on oxidative damage 
induced by saturated fatty acids in vitro and in vivo, in order to evaluate its potential as a 
modulator of metabolic disorders. 
 
2. MATERIALS AND METHODS 
2.1. Reagents 
[Nle4,D-Phe7]-α-melanocyte-stimulating hormone (NDP-MSH) was purchased from Bachem 
(CA, USA). Sodium palmitate was purchased from Santa Cruz Biotechnology (TX, USA). 
Bovine serum albumin, Fraction V, fatty acid free was obtained from Roche (Grenzach, 
Germany). JKC363 was purchased from Tocris Bioscience (MO, United States). Fetal 
bovine serum (FBS) was obtained from Natocor (Cordoba, Argentina). Nrf2 antibody (Novus) 
was kindly provided by Dr. Cymeryng (CEFYBO, UBA-CONICET). DMEM/F-12, DMEM, L-
Glutamine and antibiotics were purchased from Invitrogen Life Technologies (CA, USA). All 
other media and supplements were obtained from Sigma-Aldrich Corporation unless 
specified otherwise. 
 
2.2. Cell cultures 
Primary astrocyte culture: Astrocytes were prepared from rat cerebral cortex tissue of 1- to 
2-day old postnatal Wistar rat pups as described previously22. Cells were maintained in 
DMEM/F-12 medium containing10% FBS, 50 µg/ml streptomycin, 50 U penicillin in 75 cm2 
poly-L-lysine coated culture flasks at 37°C in 5% CO2. Cell culture medium was changed 
twice a week. Cells were trypsinized and subcultured and, after 2–3days of stabilization, 
incubated with the drugs in MEM containing 6 mM L-glutamine, 50 µg/ml streptomycin, and 
50 U/ml penicillin. Cultures were routinely more than 95% pure astrocytes as assessed by 
glial fibrillary acidic protein (GFAP) immunostaining. 
Cell treatments: Sodium palmitate was conjugated to bovine serum albumin (BSA) after 
both components were first solubilized separately as described by Pike Winer25. Briefly, 
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acid-free BSA was dissolved in 150 mM NaCl and warmed up to 37°C with continuous 
stirring. Solubilized PA was combined with BSA at a molar ratio of 6:1 (PA/BSA), stirring at 
37°C for 1 h, and the final concentration was set at 1 mM. The conjugated PA–BSA was 
aliquoted and stored at −20°C.Vehicle stock solution was prepared using the same protocol 
without PA. Astrocytes were incubated with PA and NDP-MSH alone or in combination for 2 
h to determine ROS generation, for 6 h to evaluate Nrf2 nuclear translocation and gene 
expression and for 24 h to determine enzymatic activity. Control astrocytes were incubated 
with vehicle solution.  
 
2.3. In vivo experiments 
Animals: Two month old male Wistar Kyoto rats were obtained from the School of 
Veterinary Science, National University of La Plata. At the start of the experiment the 
animals were weighted (mean body weight: 286.22 ±4.64 g) and were randomly assigned to 
either a standard diet (SD, Asociación Cooperativas Argentinas, having the following 
composition, w/w: 23% proteins, 5% fat, 6% fibre, 10% minerals and 56% starch and vitamin 
supplements) or a high-fat diet (HFD; 50% w/w bovine fat added to SD), as described by Lee 
et al26. There were no significant differences in body weight between groups before the 
experimental diets were administered, as all rats had been kept on a regular chow diet. Rats 
were housed in standard caging with a 12/12 h light/dark cycle and ad libitum access to 
water and their respective diet unless otherwise noted. HFD was replaced daily to avoid 
rancidity. Rats were administered the HFD or SD for 8 weeks. Energy concentrations were 
2900 kcal/kg for SD and 5950 kcal/kg for HFD. 
Cannulations: After 7 weeks on the HFD or SD diet, cannulas were placed under 
stereotaxic guidance into either the right or left lateral cerebral ventricle of the rats as 
described by Caruso19. Briefly, rats were anesthetized with Xylazine (10 mg/kg) and 
Ketamine (50 mg/kg) and placed into a stereotaxic frame. A 22-gauge guide sleeve was 
lowered into either the right or the left lateral cerebral ventricle according to the coordinates 
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secured to the skull with screws and dental acrylic. Animals were placed in individual cages 
and allowed to recover for 7 days. 
Procedure: Animals were fasted overnight and on the day of euthanasia rats received an 
intracerebroventricular (ICV) injection of either saline (5 µl/rat) or NDP-MSH (1 µg/5 µl/rat). 
During the next 4 h, animals were fed and then euthanized by decapitation. Trunk blood was 
collected, allowed to clot at RT and spun at 3000 rpm for 10 min; plasma was separated and 
stored at −20°C for further biochemical assay. After euthanasia, a hypothalamic fragment 
(MBH) that included the arcuate and periventricular nuclei and the median eminence was 
dissected and immediately processed for either RT-qPCR or enzymatic activity assay. 
Caloric intake: Caloric intake was calculated by multiplying the amount (g) of food 
consumed per day by the caloric concentration (kcal/g)of each diet. 
Serum biochemical determinations: Serum glucose, triglycerides, cholesterol, and insulin 
were measured in a biochemical analysis lab (Buenos Aires, Argentina) that processes 
animal samples. Measurements were performed using enzymatic assays: glucose oxidase 
assay for glucose (sensitivity: 0.54 mg/dl), glycerol-3-phosphate oxidase/peroxidase assay 
for triglycerides (sensitivity: 0.8 mg/dl), cholesterol esterase/oxidase/peroxidase assay for 
cholesterol (sensitivity: 0.63 mg/dl) and chemiluminescence assay for insulin (sensitivity: 
0.03 µUI/ml). 
TNF-α level: TNF-α concentration was measured using a commercial kit (Invitrogen) 
following the manufacturer’s instructions. Assay sensitivity was 4 pg/ml. All samples were 
run in duplicate in the same assay for all analyses.  
 
2.4. Superoxide dismutase (SOD) activity 
Total SOD activity was measured by the method described by Misra and Fridovich28. This 
method is based on the inhibition of superoxide-dependent epinephrine auto-oxidation in a 
spectrophotometer adjusted at 480 nm. A 50 % inhibition of epinephrine auto-oxidation is 
defined as one unit of SOD, and the specific activity (U SOD/mg protein) was expressed as 
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2.5. γ-Glutamate cysteine ligase (γ-GCL) activity 
The activity of γ-GCL was measured by a fluorescence-based microtiter plate assay as 
described by Correa et al.29 with minor modifications. Briefly, after cell lysis and 
centrifugation, an aliquot was reserved for protein content analysis. Another aliquot was 
mixed with the reaction cocktail (400 mM Tris buffer, 20 mM L-glutamic acid, 2 mM EDTA, 20 
mM sodium borate, and 40 mM ATP freshly added). The reaction was initiated by adding 2 
mM cysteine. After incubation, reaction was stopped with 200 mM 5-sulfosalicylic acid. The 
amount of γ-glutamylcysteine (γ-GC) formed was measured by 2,3-
naphthalenedicarboxaldehyde (NDA, Invitrogen) fluorescence. Fluorescence was read in a 
Synergy HT microplate reader (Biotek, USA) at 485 nm/528 nm. γ-GCL activity was 
calculated in moles γ-GC/min/mg protein and presented as a percentage of control 
conditions. 
 
2.6. Glutathione (GSH) measurement 
GSH levels were determined by a fluorescence based assay30 with modifications. Astrocytes 
were treated for 2 or 24 h, then conditioned medium was saved and cells were collected in 
Locke Buffer (10 mM HEPES, 5.5 mM KCl, 10 mM glucose, 5 mM NaHCO3, and 130 mM 
NaCl). After sonication, cells were centrifuged at 12,000 rpm for 30 min. Supernatant aliquots 
were saved for protein determination by the Bradford assay. Conditioned medium and 
supernatant samples were diluted with an equal volume of 200 mM5-sulfosalicylic acid and 
kept on ice for 15 min. After vigorously vortexing, samples were centrifuged at 12,000 rpm for 
3 min. 20 μl standard curve of GSH, supernatants and conditioned medium samples were 
loaded in a 96-well plate in duplicate. 180 l/well of NDA solution (50 mM Tris pH 10, 0.5 N 
NaOH, 10 mM NDA) were added to every well and the plate was incubated for 30 min in the 
dark at RT. Fluorescence was read in a Synergy HT microplate reader (Biotek, USA) at 485 
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2.7. Reactive oxygen species (ROS) determination 
Intracellular ROS levels were detected using 2’-7’-dichlorofluorescein diacetate (DCFH-DA) 
which when hydrolyzed within the cell is oxidized to fluorescent dichlorofluorescein (DCF) as 
described by Saba et al.31. Cells were seeded onto 96-well plates at a density of 3 × 104 
cells per well. They were pre-incubated with 10 µM DCFH-DA for 30 minutes at 37°C. Then, 
the cells were exposed to PA with or without 0.1 µM NDP-MSH for 2 h. Fluorescence 
intensity was measured using a Synergy HT microplate reader with filters at 485 nm 
excitation and 520 nm emission. 
 
2.8. Cell viability assay 
Cell viability was assessed by the 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium 
bromide (MTT) reduction assay32. Briefly, cells were washed in Krebs buffer and incubated 
for 4 h with 110 μl of a 0.5 μg/ml MTT-Krebs buffer solution. Formazan crystals obtained 
from MTT reduction were dissolved in 100 μl of a 0.04 N HCl-isopropanol solution. OD was 
measured in a microplate spectrophotometer (Bio-Rad) at 595 nm and presented as a 





To examine the nuclear translocation of Nrf2, immunocytochemistry was performed following 
the Kundu et al. protocol33 with minor modifications. Cells were washed in PBS and fixed in 
4% paraformaldehyde (PFA) for 10 minutes at RT, permeabilized with PBS-triton X 0.2%, 
and blocked with PBS-Tween 0.1%+10% goat serum. Then, slides were incubated overnight 
at 4°C with anti-Nrf2 antibody (1:50, Novus). After washing in PBS, cells were further 
incubated with goat anti-rabbit IgG conjugated with fluorescein (1:200, Vector 
Laboratories)for 1 hour at RT. Slides were mounted in Vectashield mounting medium (Vector 
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primary antibodies. Staining was visualized in a fluorescence microscope (Axiophot; Carl 
Zeiss, Jena, Germany). Quantification of fluorescence intensity was done with ImageJ 
Software (NIH, USA). 
 
2.10. Reverse transcriptase-real time polymerase chain reaction (RT-qPCR) 
Total RNA from cultured astrocytes (1 × 106 cells) and from hypothalamus was extracted 
using Trizol reagent (Invitrogen) following the manufacturer’s protocol. Two micrograms of 
total RNA were treated with 1 U RQ1 RNase free DNase (Promega Corporation, WI, USA) at 
37°C for 10 min, and reverse-transcribed as described before34. Products of the RT reaction 
were amplified using specific primers and SYBR Green Select Master Mix (Invitrogen Life 
Technologies) on a StepOne™ Real-Time PCR System (Applied Biosystems). Primer 
sequences are detailed in Table 1. PCR product specificity was verified by melting curve 
analysis. No-RT controls were performed by omitting the reverse transcriptase enzyme in 
the RT reaction, and no-template controls were performed by addition of nuclease-free water 
instead of cDNA. Gene expression was normalized to the endogenous reference gene 
HPRT by the ΔΔCt method35 using Step-One Software (Applied Biosystems), and expressed 
as fold-changes relative to the control group. 
 
2.11. Statistical analysis 
Data were analyzed by one sample t test, Student’s t test, one-way analysis of variance 
(ANOVA) or two-way ANOVA followed by Bonferroni’s multiple comparisons test, as 
required by the experimental design. GraphPad Prism 5 Software was used (GraphPad 
Software, CA, USA). Differences with a value of p<0.05 were considered statistically 
significant. 
 
2.6. Ethics Statement 
Experimental procedures were approved by the Institutional Committee for the Care and Use 
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Argentina (resolution n° 2746/2013) and were carried out in compliance with the guidelines 
of the NIH Guide for the Care and Use of Laboratory Animals 
 
3. RESULTS 
3.1. NDP-MSH prevented PA-induced ROS production in astrocytes 
In order to determine PA working concentration, we tested cell viability and ROS production 
in astrocytes exposed to different doses of PA. Astrocyte viability was not significantly 
different from control after treatment with PA at 50 µM and 100 µM. However, concentrations 
of 200 µM or higher induced cell death in a dose-dependent manner (Fig. 1a). PA also 
induced astrocyte ROS production in a concentration-dependent manner (Fig. 1b). 
To test the effect of NDP-MSH on ROS production, cells were co-incubated for 2 h with PA 
(100 µM) and NDP-MSH (0.1 µM). We observed that ROS production was significantly 
decreased by NDP-MSH. To determine whether MC4R is involved in NDP-MSH effects on 
ROS production we treated cells with JKC363 (10 nM), a potent and selective MC4R 
antagonist. JKC363 completely blocked NDP-MSH effect on ROS levels induced by PA (Fig. 
1c). Neither NDP-MSH nor JKC363 alone modified basal ROS levels (Fig. 1c). 
 
3.2. PA activated the Nrf2 pathway in astrocytes 
Nrf2 is the master transcription factor that regulates basal and inducible expression of 
antioxidant proteins, detoxifying enzymes and xenobiotic transporters36. In basal conditions, 
Nrf2 is located in the cytoplasm; when activated, it migrates to the nucleus36. Since PA 
exhibits pro-oxidant properties, we evaluated the effect of PA on Nrf2 activation by 
determining its intracellular localization by immunocytochemistry. Astrocytes were exposed 
to 100 μM PA with or without 0.1 μM NDP-MSH co-incubation for 6 h. Treatment with PA 
strongly increased Nrf2 nuclear translocation and NDP-MSH co-treatment reduced nuclear 
fluorescence intensity compared to PA alone (Fig. 2a). Interestingly, NDP-MSH alone 










This article is protected by copyright. All rights reserved. 
Next, we investigated whether these results correlated with mRNA levels of Nrf2-dependent 
genes. γ-GCL catalytic subunit (GCLc), γ-GCL modifier subunit (GCLm) and heme-
oxygenase 1 (HO-1) gene expression were evaluated by RT-qPCR. PA increased mRNA 
levels of GCLc (Fig 2c), GCLm (Fig. 2d), and HO-1 (Fig. 2e),whereas PA+NDP-MSH-
treatment decreased them. Surprisingly, NDP-MSH alone did not modify their expression.  
Brain derived neurotrophic factor (BDNF) plays an important role in neuronal survival and it 
has been reported to prevent oxidative damage in primary neuronal cultures and  neuronal 
cell lines by increasing GSH levels and activity of antioxidant enzymes37. Our group 
demonstrated that melanocortins stimulate BDNF expression in astrocytes34, and therefore 
we tested NDP-MSH effect on PA-challenged astroglial cells. PA reduced BDNF gene 
expression, an effect significantly prevented by NDP-MSH co-incubation. As we reported 
before, NDP-MSH alone increased BDNF mRNA levels (Fig. 2f) 
 
3.3. NDP-MSH enhanced SOD and γ-GCLactivity in astrocytes 
To determine the mechanism by which NDP-MSH reduced ROS levels we evaluated the 
activity of SOD and γ-GCL antioxidant enzymes. NDP-MSH increased SOD activity 2-fold 
compared to control conditions after 24 h of incubation (Fig. 3a). Under PA-oxidative insult, 
SOD activity was reduced by about 65% compared to basal value and this effect was 
completely prevented by NDP-MSH (Fig. 3a).NDP-MSH markedly increased the enzymatic 
activity of γ-GCL in a dose-dependent manner (Fig. 3b). Notably, a remarkable 5-fold 
increase was observed in the presence of PA+NDP-MSH (Fig. 3c), even though PA alone 
did not change γ-GCL activity. 
 
3.4. NDP-MSH increased GSH levels in astrocytes 
GSH is the main endogenous antioxidant compound, its rate of synthesis depending on γ-
GCL activity. Considering that NDP-MSH reduced PA-induced ROS production while 
increasing γ-GCL activity, as a next step, we evaluated the effect of this melanocortin on 










This article is protected by copyright. All rights reserved. 
GSH intracellular levels but stimulated GSH extracellularly (Fig. 4a). However, when NDP-
MSH was co-incubated with PA for 2 h, it enhanced both intracellular and extracellular GSH 
concentrations (Fig. 4b and c). In both cases, PA itself did not modify GSH production (Fig. 
4b and c). 
 
3.5. Effect of HFD and NDP-MSH on calorie intake and biochemical parameters 
-MSH plays a key role in energy homeostasis, inhibiting feeding behavior through MC4R 
activation. Our group has studied anti-inflammatory actions of melanocortins in the CNS, 
showing that MC4R is involved in this effect, but little is known about a possible effect of 
melanocortins on the oxidative component of inflammation. Therefore, we decided to 
investigate the effect of NDP-MSH treatment on the antioxidant response in animals fed a 
HFD. To do so, rats were exposed to either SD (5% fat) or HFD (50% fat) for 8 weeks. Daily 
calorie intake and weight gain were registered during this period. As expected, HFD-fed rats 
consumed more calories than SD group (Fig. 5a). However, after the 8th week of exposure 
to each diet, there were no differences in weight gain (Fig. 5b). At the end of the experiment, 
animals were fasted overnight, and then injected ICV with saline or NDP-MSH, re-fed, and 
euthanized 4 h later. 
Figure 6a depicts 4-h calorie intake in response to NDP-MSH in SD and HFD groups. 
Consistent with reported anorexigenic actions of melanocortins, NDP-MSH treatment 
reduced calorie intake in SD-fed rats. However, this effect was not observed in animals 
exposed to HFD. Biochemical determinations showed that HFD per se did not modify any 
parameter. NDP-MSH reduced serum glucose levels in SD and HFD groups (Fig. 6b). 
Triglyceride levels markedly decreased upon NDP-MSH stimulation in SD-fed rats. In 
contrast, this effect was not observed in animals fed a HFD (Fig. 6c). NDP-MSH impact on 
serum insulin levels differed in function of the diet administered, inducing an increase in SD 
group (Fig. 6d) and a decrease in HFD group (p=0.0603). Treatment did not modify serum 
cholesterol levels (Fig. 6e) in either SD or HFD-fed animals. As we mentioned before, high 
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weight regulation2. Considering the anti-inflammatory actions of melanocortins, we 
measured TNF- production in our model. Surprisingly, neither diet nor NDP-MSH altered 
serum levels of this cytokine. 
 
3.6. Effect of HFD and NDP-MSH on the antioxidant response 
We investigated the effect of NDP-MSH treatment on antioxidant response in the 
hypothalamus. We observed that after 4 h of treatment NDP-MSH increased SOD activity in 
SD-fed rats (Fig. 7a), but had no effect on animals exposed to HFD. Moreover, HFD by itself 
did not modify SOD activity (Fig. 7a). Next, we studied Nrf2 pathway byRT-PCR, determining 
Nrf2, GCLm, and GCLc mRNA levels. Neither NDP-MSH nor HFD significantly modified 
expression of the aforementioned genes (Fig. 7b, c and d). 
 
3.7. Effect of HFD and NDP-MSH on BDNF and MC4R expression 
BDNF has been reported to exert antioxidant action, and its hypothalamic expression 
augments in response to melanocortins38. For this reason, we evaluated BDNF and MC4R 
expression in our model. HFD reduced mRNA levels of BDNF (Fig. 8a) and MC4R (Fig. 8b) 
and, consistent with the lack of effect of NDP-MSH on biochemical and antioxidant 
parameters upon HFD exposure, NDP-MSH did not revert the decrease in MC4R and BDNF 
expression induced by the diet. Surprisingly, NDP-MSH did not increase expression of these 
genes in the SD group, an effect we previously detected when α-MSH was administered by 
intraperitoneal injection39. On the contrary, we found that in cultured astrocytes PA (100 µM) 
induced a 34% reduction in MC4R mRNA levels compared to control group, while co-
incubation with NDP-MSH (0.1 µM) induced a significant 46.6% increase in MC4R 
expression compared to control group, indicating that NDP-MSH might act differentially in 
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4. DISCUSSION 
Obesity has been associated with chronic low-grade inflammation that affects peripheral 
tissues and the CNS. Saturated fatty acids are elevated in plasma of obese patients40. Since 
they can cross the blood brain barrier they contribute to activation of glial cells by triggering 
neuroinflammation41 which may lead to neurodegeneration. Oxidative damage is involved in 
the pathogenesis of metabolic diseases and HFD has been reported to trigger oxidative 
stress42. Moreover, PA induces expression of pro-inflammatory cytokines in astrocytes10 and 
apoptosis of neurons and astrocytes by increasing oxidative stress43. Astrocytes perform 
several physiological functions to maintain brain homeostasis, and their involvement in 
obesity-related processes is beginning to be understood. Melanocortins exert anti-
inflammatory and neuroprotective effects on the CNS18,22. However, antioxidant effects of 
melanocortins in the brain are unknown. Therefore, we investigated the effect of NDP-MSH, 
an -MSH analogue, on oxidative stress in PA-treated astrocytes and in a model of HFD. In 
the present work we demonstrated that melanocortins exerted antioxidant actions in 
astrocyte and in the hypothalamus of male rats. 
PA-stimulated ROS production has been studied in different cells including astrocytes12. In 
this study, we report for the first time that NDP-MSH, through MC4R, reduces ROS levels in 
astrocytes challenged with PA. Astrocytes are key players in defense against oxidative 
insults37. In an oxidative context, astroglial cells respond by changing the expression of 
several genes regulated by Nrf2, the master redox transcription factor. Previous studies 
have shown that PA induces Nrf2 expression in hepatocyte primary cultures44 and in the 
normal liver cell line QZG45. Furthermore, PA activates Nrf2 pathway in mouse hepatoma 
and in mouse embryonic fibroblast cell lines46. -MSH also reverses oxidative stress induced 
by UV radiation through Nrf2 activation in human skin cells24. Our experiments showed that 
Nrf2 and its target genes GCLc, GCLm and HO-1 were positively regulated by PA and that 
NDP-MSH reversed this effect. Considering that both pro-oxidant compounds and ROS 
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increased ROS levels. Given that NDP-MSH reduces ROS production, we suggest that ROS 
reduction could be responsible for NDP-MSH inhibitory action on Nrf2 nuclear translocation. 
Interestingly, NDP-MSH alone reduced Nrf2 translocation without modifying ROS levels. 
JNK and p38 MAPK have been reported to induce Nrf2 phosphorylation, facilitating nuclear 
translocation of this transcription factor47. In other studies, melanocortins were shown to 
inhibit JNK and p38 activity in HEK293 cells48 and in a model of Alzheimer’s disease49, 
respectively. Considering this background, we could suggest that reduction in Nrf2 
translocation induced by NDP-MSH could be a consequence of inhibition of JNK and p38 
MAPK. 
SOD activity is reduced in embryonic cardiomyocytes exposed to PA50. Concordantly, in our 
model PA lowered SOD activity and NDP-MSH treatment restored enzymatic activity to 
control levels in cultured astrocytes. Even in basal conditions NDP-MSH increased SOD 
activity 2 fold, thereby indicating that melanocortins have antioxidant action per se. Since 
NDP-MSH did not activate the Nrf2 pathway in our model, it is likely that the aforementioned 
transcription factor is not involved in the NDP-MSH effect on SOD activity. Studies indicate 
that PPAR-γ activation increases SOD activity and synthesis in hippocampus51. Considering 
that our group has demonstrated that melanocortins induce expression of PPAR-γin 
astrocytes23, we hypothesize that increased SOD activity could be mediated by this nuclear 
receptor. Further studies are needed to prove this hypothesis. 
GSH is the main antioxidant compound of the cell, its synthesis rate limiting step catalyzed 
by γ-GCL. Our results show that NDP-MSH protected astrocytes against oxidative damage, 
stimulating GSH synthesis by increasing γ-GCL activity. Increased GSH release from 
astrocytes could also support survival of neurons52. Contrary to observations in other cell 
types53, in our experiments PA did not modify γ-GCL activity despite increasing mRNA levels 
of both γ-GCL subunits. Conversely, NDP-MSH stimulated enzymatic activity without 
modifying mRNA levels. Given that γ-GCL activity is regulated at multiple levels54, it is 
possible that PA affects transcriptional activity whereas NDP-MSH induces post-
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in astrocytes31, and in the present work, we show that NDP-MSH prevented the reduction in 
BDNF expression induced by PA, suggesting that BDNF could be a mediator of NDP-MSH 
antioxidant effect in astrocytes. 
Hypercaloric diets have extensive harmful effects, impacting multiple organs and systems 
including the CNS. In vivo studies show that high-fat feeding compromises learning and 
memory55,56, induces neuron death in the hippocampus and hypothalamus4, and triggers 
oxidative stress in different brain areas42. Therefore, we decided to test the effect of 
melanocortins on antioxidant defense using an in vivo model of high-fat feeding. 
Interestingly, animals fed a HFD did not gain more weight than SD-fed rats despite 
consuming more calories per day. Similar to our results several studies have shown no 
difference in body weight between animals, from different species and strains, fed a SD or a 
HFD for 8 weeks or longer. For instance, HFD exposure during 8 weeks affected body 
weight in Long-Evans and Wistar rats but not in Sprague-Dawley rats57. Similarly, Marques 
et al. indicate that Wistar rats increased body weight after consuming HFD for 4 weeks while 
Sprague-Dawley rats showed significant weight difference after 7 weeks. In addition, neither 
triglycerides nor insulin levels were affected by HFD in both strains58. C57BL/6J mice 
showed weight gain after 8 week in males and after 15 week in females59. On the other, no 
difference in body weight in C57BL/6J male mice after 16 weeks of HFD exposure has also 
been reported60. The same could apply for changes in cytokines release. We found no 
changes in TNF-α release in our experimental model. Accordingly, an increased in TNF-α 
levels was found after prolonged HFD feeding (24 weeks) in C57BL/6J mice61. Contradictory 
results about changes in IL-1β release have also been reported. HFD did not increased 
plasma levels of IL-1β in Sprague-Dawley rats after 8 weeks feeding a HFD57 while serum 
levels of IL-1β were markedly increased after 4 weeks but not at 16 weeks of HFD 
consumption in C57BL/6J mice60, indicating once more differences due to the experimental 
model. It is noteworthy that different HFD formulations have been used in the reports 
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weight difference, including the use of different fat sources (lard, vegetable oil, margarine, 
etc), the different duration of diet exposure, species, and animal strain. 
Since HFD did not produce alterations in biochemical or in hypothalamic parameters and did 
not increase TNF- levels, we conclude that our in vivo model did not develop metabolic 
syndrome characteristics. However, given that high-fat feeding induces hypothalamic 
changes before the onset of peripheral inflammation, metabolic disturbances, and weight 
gain6, our model could be useful to evaluate early stages of this process. ICV treatment with 
NDP-MSH reduced calorie intake in SD-fed animals, as it was described previously62. This 
calorie intake reduction may account for reduced plasma glucose and triglyceride levels in 
SD-animals. Insulin concentration tended to be higher in HFD-fed rats, suggesting that these 
animals might develop insulin resistance, given that higher levels of insulin are needed to 
maintain glucose concentrations similar to control animals. It has been reported that central 
administration of -MSH improves insulin action on glucose uptake and production63. In view 
of the aforementioned, we could suggest that lower insulin levels are able to reduce blood 
glucose in HFD group treated with NDP-MSH. However, this effect is opposite to NDP-MSH 
action in SD-fed rats which show elevated insulin concentration. 
Reported data on the impact of HFD on MC4R expression are contradictory. Some studies 
indicate that high-fat feeding does not change MC4R expression64, whereas others show 
that mice exposed to a HFD have higher mRNA levels of the receptor and better 
responsiveness to short-term treatments with MC4R agonists65. It is noteworthy that clinical 
studies with potent MC4R agonists were ineffective to treat obesity66. In line with this finding, 
several studies reported that HFD-fed rats showed a reduction in MC4R mRNA levels67, 
central resistance to MC4R agonists64, and less binding to radio-labeled MC4R agonists in 
the hypothalamus68. Concordant with these studies, our results show that HFD exposure for 
8 weeks reduced hypothalamic MC4R expression despite neither increasing body weight nor 
inducing metabolic syndrome, which reinforces the suggestion that hypothalamic changes 
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Regarding antioxidant response, we observed that NDP-MSH increased SOD activity in 
animals exposed to SD. Astrocytes could contribute, at least partially, to this effect, 
considering results observed in vitro. Although PA reduced SOD activity in astrocytes, HFD 
did not change hypothalamic SOD activity. Interestingly, in HFD group, NDP-MSH did not 
increase SOD activity. So, it is likely that the lack of melanocortin action on SOD activity in 
HFD-fed animals could be due to decreased MC4R expression in the hypothalamus. 
Expression of antioxidant genes was not modified by either diet or treatment, differing from 
in vitro experiments where PA stimulated Nrf2 pathway. This data could be explained by the 
presence of neurons and other cells that may be affected differently than astrocytes when 
challenged with components of a HFD, so that the effect of the diet on astrocytes alone is 
masked when the whole hypothalamus sis studied.  
Learning deficits detected in obese animals have been linked to decreased BDNF 
expression69. In our experimental model, we observed that HFD reduced BDNF gene 
expression and NDP-MSH treatment did not reverse this effect. Surprisingly, melanocortin 
ICV injection did not modify BDNF expression even in animals fed a SD, which differs from 
the effect we detected previously when α-MSH was administered by intraperitoneal 
injection39 and suggests that peripheral mediators may be needed for -MSH action on 
central BDNF expression.MC4R has been reported to be expressed in the gastrointestinal 
system, its activation inducing glucagon-like peptide 1 (GLP-1) expression70; an analogue of 
this hormone was shown to stimulate BDNF expression in the brain71. Considering these 
data, GLP-1 could be considered as a possible mediator of the melanocortin effect on 
hypothalamic BDNF expression. 
The hypothalamus is a key player in modulating feeding behavior and energy expenditure. 
Several studies have linked obesity with mitochondrial alterations which leads to oxidative 
stress7. Then, excessive ROS production induces NFκB activation, the main mediator of the 
inflammatory response72, and modifies neuronal activity in the hypothalamus73. High-fat 
feeding and obesity are associated with hypothalamic inflammation and reactive gliosis in 
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is not fully understood. The present study demonstrated that NDP-MSH increased 
antioxidant enzyme activity and GSH levels in astrocytes, alleviating PA-induced oxidative 
stress and contributing to prevention of neuronal damage. In vivo, NDP-MSH exerts an 
antioxidant role by increasing SOD activity in SD-fed animals, suggesting that melanocortin 
antioxidant action added to their anti-inflammatory activity could protect neurons.  However, 
NDP-MSH fails to show the same effect in the HFD group, in which hypothalamic MC4R 
expression is reduced. These results underscore the importance of α-MSH in hypothalamic 
function and point to early disruptions in the melanocortin circuit in an HFD context as 
potential contributors to hypothalamic malfunction which may lead to metabolic disorders. 
Further research is needed in order to elucidate the mechanism of HFD-induced damage in 
the hypothalamus and how alteration of the melanocortin system contributes to perpetuate 
food intake dysregulation. Better understanding of these processes will allow us to develop 
new therapeutic strategies for metabolic diseases. 
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FIGURE LEGENDS 
Figure 1 - NDP-MSH prevented PA-induced ROS production through MC4R. (a) 
Astrocytes were treated with increasing PA doses for 24 h. Cell viability was determined by 
MTT assay. Values are the mean ± SEM of 8 determinations per group of 1 representative 
experiment of 2 independent ones. Data were analyzed by comparing each dose of PA with 
its respective control by Student’s t test ***p<0.001 vs. control. (b) Astrocytes were treated 
with increasing concentrations of PA for 2 h and ROS production was determined. Values 
are the mean ± SEM of 8 determinations per group of 1 representative experiment of 2 
independent ones. Data were analyzed by comparing each dose of PA with its respective 
control by Student’s t test ***p<0.001 vs. control. (c) Astrocytes were incubated with PA 
(100 µM) in presence or absence of NDP-MSH (0.1 µM) and/or JKC363 (10 nM) for 2 h and 
ROS production was determined. Values are the mean ± SEM of fluorescence intensity 
(arbitrary units) of 8 determinations per group of 1 representative experiment of 3 
independent ones. Data were analyzed by one way ANOVA followed by Bonferroni’s 
multiple comparison test F(5, 42) = 99.47; ***p<0.001 vs. control; ^p<0.05; ^^p<0.01 vs. 
PA+NDP-MSH. 
 
Figure 2 - NDP-MSH prevented Nrf2 nuclear translocation and Nrf2-dependent gene 
expression induced by PA and stimulated BDNF expression. Astrocytes were incubated 
for 6 h with PA (100 µM) in presence or absence of NDP-MSH (0.1 µM). (a) Representative 
images for Nrf2 immunostaining of 1 representative experiment of 3 independent ones. (b)  
Nuclear fluorescence intensity (arbitrary units) was quantified using ImageJ Software. Data 
represent mean ± SEM of 100-175 cells per group of 1 representative experiment of 3 
independent ones and were analyzed by one way ANOVA followed by Bonferroni’s multiple 
comparison test F(3, 577) = 235.4; ***p<0.001 vs. control; ^^^p<0.001 vs. PA. (c) GCLc, (d 
GCLm, and (e) HO-1 expression was determined by RT-qPCR after 6 h-treatment with PA 
(100 µM) in presence or absence of NDP-MSH (0.1 µM). Data represent mean ± SEM of 4-5 
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GCLm: F(2, 9) = 1.92, HO-1: GCLm: F(2, 15) = 3.818, *p<0.05, ***p<0.001 vs. control; ^^p<0.01 
vs. PA. (f) Astrocytes were incubated for 1 h with PA (100 µM) in presence or absence of 
NDP-MSH (0.1 µM) and BDNF expression was determined by RT-qPCR. Data represent 
mean ± SEM of 3 independent experiments and were analyzed by one way ANOVA, F(3, 12) = 
7.188; *p<0.05 vs. control; ^p<0.05 vs. PA. 
 
Figure 3 – NDP-MSH increased SOD and γ-GCL activity. (a) Astrocytes were treated for 
24 h with PA (100 µM) in presence or absence of NDP-MSH (0.1 µM) and SOD activity was 
measured using Fridovich’s technique as described in Material and Methods. Data represent 
mean ± SEM of 3 independent experiments and were analyzed by one way ANOVA followed 
by Bonferroni’s multiple comparison test, F(3, 12) = 20.49, *p<0.05,  **p<0.01 vs. control; 
^p<0.05 vs. PA. (b) Cells were incubated with increasing doses of NDP-MSH for 24 h and γ-
GCL activity was measured by Correa’s technique as described in Material and Methods. 
Data represent mean ± SEM of 3 independent experiments and were analyzed by one way 
ANOVA followed by Bonferroni’s multiple comparison test, F(3, 10) = 15.66, *p<0.05,  
**p<0.01, ***p<0.001 vs. control. (c) Astrocytes were incubated with PA (100 µM) in 
presence or absence of NDP-MSH (0.1 µM) for 24 h and γ-GCL activity was measured by 
Correa’s technique as described in Material and Methods. Data represent mean ± SEM of 4 
independent experiments and were analyzed by Kruskal-Wallis test followed by Dunn’s 
multiple comparison test *p<0.05 vs. control; ^p<0.05 vs. PA. 
 
Figure 4 – NDP-MSH increased GSH levels. (a) Astrocytes were treated with NDP-MSH 
(0.1 µM) for 24 h and GSH levels were determined by fluorescence assay. Data represent 
mean ± SEM of 4 independent experiments and were analyzed by Student’s t test 
***p<0.001 vs. control. Astrocytes were exposed to PA (100 µM) in presence or absence of 
NDP-MSH (0.1 µM) for 2 h to determine intracellular (b) and extracellular (c) GSH levels. In 
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by one way ANOVA followed by Bonferroni’s multiple comparison test, intracellular GSH F(3, 
23) = 4.187, extracellular GSH: F(3, 24) = 2.821, *p<0.05 vs. control. 
 
Figure 5 – Calorie intake and weight gain of animals fed a SD or a HFD. (a) Calorie 
intake was calculated by multiplying energy concentration of each diet (kcal/g) by the 
amount of food (g) consumed per day. (b) Weight gain was calculated as the difference 
between initial and final body weight. Data represent mean ± SEM of n=11-15 animals per 
group and were analyzed by Student’s t test. ***p<0.001 vs. SD 
 
Figure 6 – Effect of NDP-MSH on calorie intake, biochemical parameters and TNF-α 
levels in animals fed SD or HFD. Animals were exposed to either SD (5% fat) or HFD 
(50% fat) for 8 weeks. Rats were fasted overnight and on the day of euthanasia were 
injected ICV with either saline or NDP-MSH. After 4 h animals were killed. (a) Calorie intake 
was calculated by multiplying energy concentration of each diet (kcal/g) by the amount of 
food (g) consumed in the last 4 h of the experiment. (b) Glucose, (c) tryglicerides, (d) insulin, 
and (e) cholesterol were measured in trunk blood after 4 h treatment with either saline or 
NDP-MSH. (f) Hypothalamic TNF-α levels were determined by ELISA. Data represent the 
mean ± SEM of n=5-8 animals per group and were analyzed by two way ANOVA *p<0.05; 
**p<0.01; ***p<0.001 vs. SD saline; ^^^p<0.001 vs. HFD saline. 
 
Figure 7 – Effect of NDP-MSH on hypothalamic antioxidant response in animals fed 
with SD or HFD. (a) SOD activity was measured using Fridovich’s technique as described in 
Materials and Methods. (b) Nrf2, (c) GCLc, and (d) GCLm gene expression was determined 
by RT-qPCR. Data represent the mean ± SEM of n=5-8 animals per group and were 











This article is protected by copyright. All rights reserved. 
Figure 8 – Effect of NDP-MSH on hypothalamic BDNF and MC4R gene expression in 
animals fed SD or HFD. (a) BDNF and (b) MC4R expression was determined by RT-qPCR. 
Data represent the mean ± SEM of n=5-8 animals per group and were analyzed by two way 
ANOVA *p<0.05 vs. SD saline; ^p<0.05 vs. SD NDP-MSH. 
 
Figure 9 - Graph depicting the antioxidant action of NDP-MSH in astrocytes. In vitro 
stimulation of astroglial MC4R increased SOD and γ-GCL activity, BDNF expression and 
GSH levels, alleviating PA-induced ROS production in astrocytes and possibly contributing 
to neuron protection. 
 




Gene Forward primer sequence Reverse primer sequence 
HO-1 5’-TCTATCGTGCTCGCATGAACA-3’ 5’-TCTTCTGTCACCCTGTGCTTGA-3’ 
GCLc 5’-TCTGCCCAATTGTTATGGCTTT-3’ 5’-GTCTGACACGTAGCCTCGGTAA-3’ 
GCLm 5’-CGTCACTGAGGCGTGAATGT-3’ 5’-CGCCAGGGAGGTACTCAAAC-3’ 
Nrf2 5’-CAAATCCCACCTTGAACACAGAT-3’ 5’-TGGGCTCTGCTAGGAAAGCA-3’ 
MC4R 5’-CCAACTGCAGCCTTCCAACT-3’ 5’-GCCCCGAGTGGTTTTTCTC-3’ 
BDNF 5’-GATGAGGACCAGAAGGTTCG-3’ 5’-TCCAGCAGAAAGAGCAGAGG-3’ 
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